NanOlogy Appoints David J. Arthur as New CEO to Enhance Drug Development Efforts David J. Arthur has been appointed as the Chief Executive Officer of NanOlogy, LLC, where he will lead the charge in drug development strategies and initiatives focused on pediatric brain cancer.

NanOlogy Appoints David J. Arthur as New CEO to Enhance Drug Development Efforts #United_States #Fort_Worth #NanOlogy #David_Arthur #LSAM